A detailed history of Core First Bank & Trust transactions in Amgen Inc stock. As of the latest transaction made, Core First Bank & Trust holds 2,286 shares of AMGN stock, worth $662,711. This represents 0.48% of its overall portfolio holdings.

Number of Shares
2,286
Previous 2,441 6.35%
Holding current value
$662,711
Previous $694,000 2.88%
% of portfolio
0.48%
Previous 0.44%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $40,726 - $49,493
-155 Reduced 6.35%
2,286 $714,000
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $53,236 - $64,262
-198 Reduced 7.5%
2,441 $694,000
Q4 2023

Mar 18, 2024

SELL
$255.7 - $288.46 $14,063 - $15,865
-55 Reduced 2.04%
2,639 $760,000
Q3 2023

Dec 18, 2023

SELL
$218.65 - $271.46 $19,678 - $24,431
-90 Reduced 3.23%
2,694 $724,000
Q2 2023

Aug 07, 2023

SELL
$214.27 - $253.37 $3,856 - $4,560
-18 Reduced 0.64%
2,784 $618,000
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $59,834 - $72,928
-265 Reduced 8.64%
2,802 $677,000
Q4 2022

Feb 15, 2023

SELL
$229.03 - $291.01 $61,838 - $78,572
-270 Reduced 8.09%
3,067 $805,000
Q3 2022

Nov 16, 2022

SELL
$224.46 - $253.15 $130,186 - $146,827
-580 Reduced 14.81%
3,337 $752,000
Q2 2022

Aug 16, 2022

SELL
$230.71 - $256.74 $112,355 - $125,032
-487 Reduced 11.06%
3,917 $953,000
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $116,870 - $129,289
-533 Reduced 10.8%
4,404 $1.07 Million
Q4 2021

Feb 10, 2022

SELL
$198.88 - $227.6 $138,420 - $158,409
-696 Reduced 12.36%
4,937 $1.11 Million
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $71,322 - $83,563
-336 Reduced 5.63%
5,633 $1.2 Million
Q2 2021

Aug 17, 2021

SELL
$233.58 - $259.14 $130,104 - $144,340
-557 Reduced 8.54%
5,969 $1.46 Million
Q1 2021

May 18, 2021

BUY
$221.91 - $258.6 $682,373 - $795,195
3,075 Added 89.1%
6,526 $1.62 Million
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $746,727 - $889,219
3,451 New
3,451 $793,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Core First Bank & Trust Portfolio

Follow Core First Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Core First Bank & Trust with notifications on news.